Non-small cell lung cancer

How do rare driver gene mutations in non-small cell lung cancer relate to age?
Non-small cell lung cancer Genetic mutations nsclc lung cancer
05-10
In-depth inventory: Dynamic panorama of anti-cancer drug research and development in 2022 (January-April)
anticancer drugs cancer Non-small cell lung cancer biopharma futibatinib immunocore kim pacritinib relatlimab
05-10
Lung cancer "no chemotherapy era" or will come to the lung cancer advanced survival or is expected to exceed 5 years?
lung cancer Advanced lung cancer chemotherapy Non-small cell lung cancer Terelizumab Carellizumab
04-29
Clinical recruitment of patients with non-small cell lung cancer, drug "peritinib"
Non-small cell lung cancer drugs clinic lung cancer
04-29
Nine immunotherapy drugs How to choose patients with non-small cell lung cancer
immunity Non-small cell lung cancer drugs Navuliyuzumab lung cancer Pabli beads Combination chemotherapy Cimipril treat chemotherapy
04-20
Zhijian Jinrui second-generation RET inhibitor APS03118 announced the results of the preclinical key study
Zhijian Jinrui depressor aps Non-small cell lung cancer tumor
04-18
A number of drugs were approved in one day, including 3 important anti-cancer drugs
Indications Terelizumab anticancer Non-small cell lung cancer Tocilizumab Ensatinib pd-1 BeiGene
04-13
Don't want to relapse, what should lung cancer patients do after surgery? Regular follow-up is not enough
lung cancer surgery Non-small cell lung cancer
04-09
Whether lung cancer patients should use immunotherapy after surgery has new evidence
lung cancer immunity chemotherapy Non-small cell lung cancer nsclc
04-06
The latest research progress of six rare targets of lung cancer, an inventory
lung cancer nsclc Non-small cell lung cancer cancer Li Guoyu Zhou Caicun Wu Fengying hospital He Ming ramalingam
04-03
Chinese expert consensus: Stage III non-small cell lung cancer adjuvant targeted therapy should pay attention to these points
Non-small cell lung cancer lung cancer egfr
04-01
finally! The targeted drug for BRAF V600E, a rare mutation in lung cancer, was officially approved
lung cancer Trimetinib Darafenib Non-small cell lung cancer melanoma
04-01
Pathological stage and typing, which has a greater impact on lung cancer survival time? The article is clear
lung cancer pathology cancer Non-small cell lung cancer cell
03-30
Lung cancer rare target therapy has advanced rapidly, and patients are no longer "afraid" because of "rare"
lung cancer nsclc Non-small cell lung cancer treat
03-26
Latest Advances in Targeted Therapy! Lung Cancer Chief Specialist Tension: Lung cancer targeted therapy ushered in a new milestone
lung cancer nsclc Non-small cell lung cancer Darafenib Trimetinib tumor
03-25
Spring is coming as scheduled, the epidemic will eventually pass| shines brightly, and the Simcere Tumor Summit Forum was successfully held!
tumor epidemic situation peak Cancer Hospital of Tianjin Medical University Shandong Provincial Cancer Hospital Non-small cell lung cancer
03-22
How long can you live after getting lung cancer? In fact, it is these 4 points that "support life"
lung cancer tumor surgery chemotherapy Non-small cell lung cancer
03-22
The first and only one in the country! The selective RET inhibitor PhuketHua is approved for thyroid cancer
Thyroid cancer Phuket selectivity Medullary thyroid cancer Non-small cell lung cancer
03-21
Immunotherapy drugs approved for new adjuvant therapy indications for lung cancer! What site neoadjuvant therapy
Navuliyuzumab lung cancer immunity chemotherapy Non-small cell lung cancer
03-15
Lung cancer treatment has three questions: drug resistance, genetic testing and immunotherapy
lung cancer immunity Genetic testing Non-small cell lung cancer Guangdong Provincial People's Hospital
03-11